| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.004 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.005 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.19 | 0.005 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.006 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.006 |